Skip to main content

Amylin Pharmaceuticals, Inc. Investor Investigation Over Possible Securities Laws Violations

  • If you are an investor in shares of Amylin Pharmaceuticals, Inc. (Public, NASDAQ:AMLN), and/or have any information relating to the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

After Amylin Pharmaceuticals lost more than 50% in stock value an investigation on behalf of investors in Amylin Pharmaceuticals (NASDAQ: AMLN) shares concerning potential violations of Federal Securities laws in connection with the New Drug Application for Amylins diabetes drug BYDUREON was announced. The investigation by a law firm on behalf of investors in AMLN shares concerns whet...

You must register (for free) or login to view the entire investigation.